ClinicalTrials.gg
Not yet recruitingNCT07684989Updated Jul 13, 2026

Comparison of Low-Dose Versus Standard-Dose Hyperbaric Bupivacaine in Spinal Anesthesia

A Phase 4 interventional study of Low-Dose Hyperbaric Bupivacaine and Standard-Dose Hyperbaric Bupivacaine in Anesthesia, Spinal, Orthopedic Procedures and Postoperative Recovery in Elderly Patients, sponsored by Mayo Hospital Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by Mayo Hospital Lahore · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The goal of this randomized controlled trial is to determine whether low-dose hyperbaric bupivacaine provides better hemodynamic stability and postoperative recovery compared with standard-dose hyperbaric bupivacaine in elderly patients undergoing lower limb orthopedic surgery under spinal anesthesia.

The main questions it aims to answer are:

  • Does low-dose hyperbaric bupivacaine reduce the incidence of intraoperative hypotension and bradycardia compared with standard-dose hyperbaric bupivacaine?
  • Does low-dose hyperbaric bupivacaine improve postoperative recovery profile compared with standard-dose hyperbaric bupivacaine?

Researchers will compare elderly patients receiving low-dose hyperbaric bupivacaine with those receiving standard-dose hyperbaric bupivacaine to determine whether a lower intrathecal dose improves cardiovascular stability and recovery without compromising the effectiveness of spinal anesthesia.

Participants will:

  • Provide written informed consent before enrollment.
  • Undergo elective lower limb orthopedic surgery under spinal anesthesia.
  • Be randomly assigned to receive either low-dose or standard-dose hyperbaric bupivacaine.
  • Have their blood pressure, heart rate, and other vital signs monitored throughout the surgical procedure.
  • Be assessed for intraoperative hypotension and bradycardia according to predefined study criteria.
  • Be evaluated for postoperative recovery parameters, including motor recovery and readiness for postoperative recovery and mobilization.

The information obtained from this study may help identify a safer and more effective spinal anesthetic technique for elderly patients undergoing orthopedic surgery.

02

Conditions studied

  • Anesthesia, Spinal
  • Orthopedic Procedures
  • Postoperative Recovery in Elderly Patients
  • Hemodynamics
  • Bupivacaine

Keywords

  • Low-Dose Hyperbaric Bupivacaine
  • Standard-Dose Hyperbaric Bupivacaine
  • Spinal Anesthesia
  • Geriatric Anesthesia
  • Lower Limb Orthopedic Surgery
  • Hemodynamic Stability
03

In context

Lead sponsor

Mayo Hospital Lahore is the lead sponsor of 16 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female patients aged 65 years and above.
  • Patients scheduled for elective lower limb orthopedic surgery under spinal anesthesia.
  • (ASA) physical status I-III.
  • Patients willing to participate and provide written .

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study.
  • to spinal anesthesia (e.g., infection at puncture site, coagulopathy, severe hypovolemia, raised intracranial pressure).
  • Known or allergy to bupivacaine.
  • Severe valvular heart disease.
  • Significant cardiac arrhythmias.
  • Uncontrolled hypertension.
  • Severe hepatic or renal impairment.
  • Pre-existing neurological disorders affecting lower limb motor or sensory function.
  • Severe spinal deformity or previous lumbar spine surgery interfering with spinal anesthesia.
  • Cognitive impairment or inability to provide .
  • Emergency orthopedic procedures.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Low-Dose Hyperbaric Bupivacaine

    Participants randomized to this group will receive low-dose hyperbaric bupivacaine for spinal anesthesia before elective lower limb orthopedic surgery. Hemodynamic parameters and postoperative recovery outcomes will be assessed according to the study protocol.

    Drug: Low-Dose Hyperbaric Bupivacaine

  • Active comparator
    Standard-Dose Hyperbaric Bupivacaine

    Participants randomized to this group will receive standard-dose hyperbaric bupivacaine for spinal anesthesia before elective lower limb orthopedic surgery. Hemodynamic parameters and postoperative recovery outcomes will be assessed according to the study protocol.

    Drug: Standard-Dose Hyperbaric Bupivacaine

Interventions

  • DrugLow-Dose Hyperbaric Bupivacaine

    Low-dose hyperbaric bupivacaine administered intrathecally for spinal anesthesia in elderly patients undergoing elective lower limb orthopedic surgery.

  • DrugStandard-Dose Hyperbaric Bupivacaine

    Standard-dose hyperbaric bupivacaine administered intrathecally for spinal anesthesia in elderly patients undergoing elective lower limb orthopedic surgery.

06

What researchers measure

Primary outcomes

  1. Incidence of Intraoperative Hypotension

    Occurrence of intraoperative hypotension following spinal anesthesia, defined as a decrease in systolic blood pressure greater than 20% from baseline or systolic blood pressure less than 90 mmHg requiring intervention.

    Time frame: From administration of spinal anesthesia until completion of surgery

Secondary outcomes

  1. Incidence of Intraoperative Bradycardia

    Occurrence of intraoperative bradycardia, defined as heart rate less than 50 beats per minute requiring pharmacological treatment.

    Time frame: From administration of spinal anesthesia until completion of surgery.

  2. Time to Complete Motor Recovery

    Time required to achieve complete motor recovery following spinal anesthesia, assessed using Bromage Score 0.

    Time frame: From completion of surgery until achievement of Bromage Score 0, assessed up to 24 hours postoperatively

  3. Time to First Ambulation

    Time from completion of surgery to the patient's first assisted ambulation.

    Time frame: Within the first 24 hours after surgery

  4. Postoperative Recovery Profile

    Assessment of recovery following spinal anesthesia, including readiness for discharge from the post-anesthesia care unit and return of motor function.

    Time frame: From completion of surgery until discharge from the post-anesthesia care unit (PACU), assessed up to 24 hours postoperatively

07

Study locations

1 site
08

References and documents

Publications

  • Lee YY, Ngan Kee WD, Muchhal K, Chan CK. Clinical comparison of 12 mg ropivacaine and 8 mg bupivacaine (with fentanyl) in spinal anaesthesia for major orthopaedic surgery in geriatric patients. Acta Anaesthesiol Scand. 2011;55(3):298-303
  • Ben-David B, Frankel R, Arzumonov T, Marchevsky Y, Volpin G. Minidose bupivacaine-fentanyl spinal anesthesia for surgical repair of hip fracture in the aged. Anesthesiology. 2000 Jan;92(1):6-10. doi: 10.1097/00000542-200001000-00007. PubMed 10638892 ↗
  • Patel A, Yadav AK, Patel PS, Kumari R, Deepesh. Comparative hemodynamic stability in low-dose versus conventional-dose bupivacaine for spinal anaesthesia in elderly patients. Int J Pharm Res Technol. 2025;15(2). doi:10.31838/ijprt/15.2.89.

Individual participant data

Plan to share: No — Individual participant data (IPD) collected during this study will not be made publicly available. Participant confidentiality and privacy will be maintained in accordance with institutional ethical guidelines and the approved study protocol. Aggregate study results may be published or presented, but individual-level data will not be shared outside the research team.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07684989
Lead sponsor
Mayo Hospital Lahore
Responsible party
Muhammad Shaheryar Bashir (Principal Investigator, Mayo Hospital Lahore) — Principal investigator
First posted
Jul 6, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Jul 13, 2026

Study contacts

Muhammad Shaheryar Bashir, MBBS, BSc, FCPS (R) CHPE, DPHN
Contact
drmsb259@gmail.com
+92-335-4377900

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion